title: Caveats of evaluating costs in critical care.
authors.forename: Albert E
authors.initials: AE
authors.lastname: Holt
authors.forename: Anthony D
authors.initials: AD
authors.lastname: Slonim
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000191:economics; D003363:Cost Control; D003362:Cost-Benefit Analysis; D003422:Critical Care / Q000191:economics* / Q000379:methods; D016527:Drug Costs; D017721:Hospital Costs; D006801:Humans; D007362:Intensive Care Units / Q000191:economics*; D011015:Pneumonia, Aspiration / Q000175:diagnosis / Q000188:drug therapy; D014481:United States
chemical_list: D000900:Anti-Bacterial Agents